| Drug Name: | Conjugated Estrogens (438-67-5) |
|---|---|
| PubChem ID: | 45357473 |
| SMILES: | CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+] |
| InchiKey: | VUCAHVBMSFIGAI-TWCWWGPMSA-M |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 372.418 |
| LogP | : | -0.0452 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 83.5 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Increase In Bone Mineral Density | Estrogen receptor (P03372) | Increase in bone mineral density [ ADR Type 1 ] | Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category